Michael J Selgelid
Overview
Explore the profile of Michael J Selgelid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberts D, Jamrozik E, Heriot G, Slim A, Selgelid M, Miller J
Sci Adv
. 2023 May;
9(18):eabn7153.
PMID: 37146140
Infectious disease control measures often require collective compliance of large numbers of individuals to benefit public health. This raises ethical questions regarding the value of the public health benefit created...
2.
Williams E, Craig K, Chiu C, Davies H, Ellis S, Emerson C, et al.
Vaccine
. 2022 Feb;
40(26):3484-3489.
PMID: 35210119
This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken...
3.
Evans N, Selgelid M, Simpson R
J Med Philos
. 2022 Feb;
47(1):72-94.
PMID: 35137173
In debates over the regulation of communication related to dual-use research, the risks that such communication creates must be weighed against against the value of scientific autonomy. The censorship of...
4.
Jamrozik E, Littler K, Bull S, Emerson C, Kang G, Kapulu M, et al.
Vaccine
. 2020 Dec;
39(4):633-640.
PMID: 33341309
This report of the WHO Working Group for Guidance on Human Challenge Studies in COVID-19 outlines ethical standards for COVID-19 challenge studies. It includes eight Key Criteria related to scientific...
5.
Jamrozik E, Selgelid M
Monash Bioeth Rev
. 2020 Dec;
38(Suppl 1):1-16.
PMID: 33326062
Interactions between microbes and human hosts can lead to a wide variety of possible outcomes including benefits to the host, asymptomatic infection, disease (which can be more or less severe),...
6.
Jamrozik E, Selgelid M
J Med Ethics
. 2020 Nov;
46(12):835-836.
PMID: 33154089
No abstract available.
7.
Jamrozik E, Selgelid M
Bioethics
. 2020 Aug;
34(8):797-808.
PMID: 32862482
Controlled human infection challenge studies (CHIs) involve intentionally exposing research participants to, and/or thereby infecting them with, micro-organisms. There have been increased calls for more CHIs to be conducted in...
8.
Jamrozik E, Heriot G, Selgelid M
J Bioeth Inq
. 2020 Aug;
17(4):709-715.
PMID: 32840856
Human infection challenge studies (HCS) have been proposed as a means to accelerate SARS-CoV2 vaccine development and thereby help to mitigate a prolonged global public health crisis. A key criterion...
9.
Shah S, Miller F, Darton T, Duenas D, Emerson C, Lynch H, et al.
Science
. 2020 Jul;
369(6500):151.
PMID: 32646992
No abstract available.
10.
Jamrozik E, Selgelid M
Lancet Infect Dis
. 2020 Jun;
20(8):e198-e203.
PMID: 32479747
COVID-19 poses an extraordinary threat to global public health and an effective vaccine could provide a key means of overcoming this crisis. Human challenge studies involve the intentional infection of...